Dr. Michael A. Curi, MD

Dr. Curi practices at University Hospital in Newark, New Jersey, part of State of New Jersey.

Dr. Curi's NPI, 1033222161, was assigned on August 15, 2006. Dr. Curi graduated from Rutgers New Jersey Medical School in 1998. Dr. Curi holds New Jersey license 25MA08741000.

Dr. Curi's primary practice is University Hospital, at 150 Bergen St, Newark, NJ 07103 in Essex County. The practice phone is (973) 972-4300.

Dr. Curi's primary practice is University Hospital in Newark, New Jersey, part of State of New Jersey. Dr. Curi is also affiliated with Jersey City Medical Center. The medical group on file is University Neuro-Ophthalmology Associates. Dmand AI also links Dr. Curi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Curi practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Curi's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Curi is licensed in New Jersey.

CMS data shows 278 Medicare services from Dr. Curi across 10 procedure codes in 2024, for 204 Medicare patients. Medicare paid $12,826 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 204 Medicare patients who saw Dr. Curi in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Curi's median patient age at 65, with 48% women.

In 2024, Dr. Curi wrote 89 Medicare Part D claims for 42 patients. 69% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $11,003 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Curi for performance year 2024, reported as part of a group. Dr. Curi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Curi, published from 2012 to 2025. 2015 was the busiest year, with 2. The most frequent topics are Vascular Patency, Arteriovenous Shunt, Surgical and Renal Dialysis. Dr. Curi has published most often in Ann Vasc Surg. Dr. Curi's most frequent co-authors are Yasong Yu, MD, Gary M. Ansel, MD and Frank J. Arena, MD.

CMS Open Payments shows 118 general payments to Dr. Curi from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Humacyte Global, Inc. paid the most, $22,674.

Dr. Curi graduated from Rutgers New Jersey Medical School in 1998.